Related Experiment Video
Updated: Feb 22, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
NELF prevents transcriptional readthrough into DNA replication zones in cancer cells
Chihiro Nakayama1,2, Qi Fang1, Yasukazu Daigaku3
1Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Abstract:
Regulation of RNA polymerase II (Pol II) transcription is closely associated with cell proliferation. However, it remains unclear how the Pol II transcription program is rewired in cancer to promote uncontrolled growth. Here, we find that expression of NELFCD, a known negative transcription elongation factor, is upregulated in colorectal tumors. Auxin-dependent protein degradation of NELF-C in combination with nascent transcript sequencing demonstrates a direct role of NELF-C on Pol II transcription in this cancer. Strikingly, we demonstrate that the acute loss of NELF-C protein globally redistributes termination factors and perturbs Pol II transcription termination. These changes drive pervasive Pol II transcription into DNA replication zones, leading to transcription-replication conflict that may block the cell cycle in G1 or early S phase. Our findings reveal a previously unrecognized role of NELF in transcription termination and highlight NELF as a potential therapeutic target in colorectal cancer.
Insights
Colorectal cancer cells upregulate NELF-C, a negative transcription elongation factor. Its loss disrupts transcription termination, causing conflicts that may block cell cycle progression, revealing NELF as a therapeutic target.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- RNA polymerase II (Pol II) transcription regulation is crucial for cell proliferation.
- The rewiring of Pol II transcription in cancer for uncontrolled growth is not fully understood.
Purpose of the Study:
- To investigate the role of NELF-CD in colorectal cancer.
- To elucidate the function of NELF-C in Pol II transcription and its implications in cancer.
Main Methods:
- Auxin-dependent protein degradation to remove NELF-C.
- Nascent transcript sequencing to analyze Pol II transcription.
- Analysis of transcription termination factors and transcription-replication conflicts.
Main Results:
- NELF-CD expression is upregulated in colorectal tumors.
- Acute loss of NELF-C perturbs Pol II transcription termination globally.
- NELF-C loss drives transcription into DNA replication zones, causing transcription-replication conflicts.
Conclusions:
- NELF plays a previously unrecognized role in transcription termination.
- NELF-C dysregulation contributes to cancer progression by inducing transcription-replication conflicts.
- NELF is a potential therapeutic target for colorectal cancer treatment.
More Related Videos
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Related Concept Videos
lncRNA - Long Non-coding RNAs
Negative Regulator Molecules
Replicative Cell Senescence
Telomeres and Telomerase
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle